NCT06123156 2026-02-18
RECTIL
University Hospital, Rouen
Phase 3 Not yet recruiting
Clinical Trials
10 trialsNCT07113275 2026-02-12
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3 Not yet recruiting
NCT07188025 2025-09-23
REACT
Erasmus Medical Center
Phase 3 Not yet recruiting
NCT07132463 2025-08-20
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Fudan University
Phase 3 Not yet recruiting
NCT06936774 2025-07-03
iRECOVER
University Hospital, Basel, Switzerland
Phase 3 Not yet recruiting
NCT06850090 2025-06-25
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial
Shandong Cancer Hospital and Institute
Phase 3 Not yet recruiting
NCT06832917 2025-03-11
NeoCaCRT-III
Shenzhen People's Hospital
Phase 3 Not yet recruiting
NCT06450574 2024-06-10
TAUTEM-T1
Corporacion Parc Tauli
Phase 3 Not yet recruiting
NCT06097416 2023-10-25
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
St. James's Hospital, Ireland
Phase 3 Not yet recruiting
NCT03975049 2019-06-05
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Not yet recruiting